ClinicalTrials.Veeva

Menu

Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Retinal Detachment

Study type

Observational

Funder types

Other

Identifiers

NCT01020656
MARIE02

Details and patient eligibility

About

Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.

Enrollment

206 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Take or no anticoagulant treatment before surgery,
  • Vitreoretinal surgery

Exclusion Criteria:none

  • No surgery
  • Anesthetic complication

Trial design

206 participants in 7 patient groups

group 1
Description:
patients with no anticoagulants used as the control group
group 2
Description:
patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol)
group 3
Description:
patients treated with aspirin
group 4
Description:
patients treated with clopidogrel therapy
group 5
Description:
patients treated with both anticoagulant and aspirin medications
group 6
Description:
patients treated with both anticoagulant and clopidogrel medications
group 7
Description:
patients treated with both aspirin and clopidogrel medications

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems